Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Contrast Media × Dermatologic × 90 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 4 Thoracic 3 CNS 3 Sarcoma 1 Head & Neck 1 Gynecologic 1 Gastrointestinal 1 Endocrine 1 Dermatologic 1 Breast 1

Conditions

Melanoma 1 Lung Neoplasms 1

Interventions

pembrolizumab 76 Nivolumab 69 Ipilimumab 36 Specimen Handling 28 Cyclophosphamide 27 Magnetic Resonance Spectroscopy 23 Biopsy 20 fludarabine 18 cemiplimab 17 trametinib 15 relatlimab 15 binimetinib 14 fludarabine phosphate 11 avelumab 11 Radiosurgery 11 Opdualag 11 encorafenib 10 Immunoglobulin G 10 dabrafenib 9 aldesleukin 9 Interleukin-2 9 Disulfides 9 CTLA-4 Antigen 9 atezolizumab 8 Paclitaxel 7 Blood Specimen Collection 7 tebentafusp 6 X-Rays 6 Standard of Care 6 Carboplatin 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07492121 2026-03-25

GAPIMET

University of Zurich

Phase 2 Not yet recruiting

DermatologicThoracic

Lung Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡